These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 34981814)

  • 61. Cancer immunotherapy.
    Schuster M; Nechansky A; Kircheis R
    Biotechnol J; 2006 Feb; 1(2):138-47. PubMed ID: 16892244
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Challenges and opportunities for monoclonal antibody therapy in veterinary oncology.
    Beirão BC; Raposo T; Jain S; Hupp T; Argyle DJ
    Vet J; 2016 Dec; 218():40-50. PubMed ID: 27938708
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Monoclonal antibodies in the treatment of cancer.
    Dillman RO
    Crit Rev Oncol Hematol; 1984; 1(4):357-85. PubMed ID: 6397268
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hybridoma technology a versatile method for isolation of monoclonal antibodies, its applicability across species, limitations, advancement and future perspectives.
    Parray HA; Shukla S; Samal S; Shrivastava T; Ahmed S; Sharma C; Kumar R
    Int Immunopharmacol; 2020 Aug; 85():106639. PubMed ID: 32473573
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The role of phage display in therapeutic antibody discovery.
    Chan CE; Lim AP; MacAry PA; Hanson BJ
    Int Immunol; 2014 Dec; 26(12):649-57. PubMed ID: 25135889
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Targeting B Cell Maturation Antigen (BCMA) in Multiple Myeloma: Potential Uses of BCMA-Based Immunotherapy.
    Cho SF; Anderson KC; Tai YT
    Front Immunol; 2018; 9():1821. PubMed ID: 30147690
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy.
    Roth KDR; Wenzel EV; Ruschig M; Steinke S; Langreder N; Heine PA; Schneider KT; Ballmann R; Fühner V; Kuhn P; Schirrmann T; Frenzel A; Dübel S; Schubert M; Moreira GMSG; Bertoglio F; Russo G; Hust M
    Front Cell Infect Microbiol; 2021; 11():697876. PubMed ID: 34307196
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cancer Antibody Engineering: Comparison of Mammalian, Yeast, Bacterial, Plants, Cell-free and Hybridoma Expression Systems.
    Ng MG; Tan HY; Ng PY; Koh RY; Voon KGL; Chye SM
    Curr Pharm Biotechnol; 2024 Jul; ():. PubMed ID: 39005118
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Phage display and hybridoma generation of antibodies to human CXCR2 yields antibodies with distinct mechanisms and epitopes.
    Rossant CJ; Carroll D; Huang L; Elvin J; Neal F; Walker E; Benschop JJ; Kim EE; Barry ST; Vaughan TJ
    MAbs; 2014; 6(6):1425-38. PubMed ID: 25484064
    [TBL] [Abstract][Full Text] [Related]  

  • 70. New developments in immunotherapy for pediatric solid tumors.
    Schultz LM; Majzner R; Davis KL; Mackall C
    Curr Opin Pediatr; 2018 Feb; 30(1):30-39. PubMed ID: 29189429
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Generation of a single-chain variable fragment phage display antibody library from naïve mice panned against Fasciola hepatica antigens.
    Norbury LJ; Basałaj K; Bąska P; Zawistowska-Deniziak A; Kalinowska A; Wilkowski P; Wesołowska A; Wędrychowicz H
    Exp Parasitol; 2019 Oct; 205():107737. PubMed ID: 31401060
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Phage display--a powerful technique for immunotherapy: 2. Vaccine delivery.
    Bazan J; Całkosiński I; Gamian A
    Hum Vaccin Immunother; 2012 Dec; 8(12):1829-35. PubMed ID: 22906938
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Immunotherapy of colorectal cancer--overview and perspectives].
    Schimanski CC; Hörner V; Kanzler S; Galle PR; Moehler M
    Z Gastroenterol; 2006 Aug; 44(8):673-81. PubMed ID: 16902899
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Monoclonal antibodies: technologies for early discovery and engineering.
    Kennedy PJ; Oliveira C; Granja PL; Sarmento B
    Crit Rev Biotechnol; 2018 May; 38(3):394-408. PubMed ID: 28789584
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A humanised murine monoclonal antibody with broad serogroup specificity protects mice from challenge with Venezuelan equine encephalitis virus.
    Goodchild SA; O'Brien LM; Steven J; Muller MR; Lanning OJ; Logue CH; D'Elia RV; Phillpotts RJ; Perkins SD
    Antiviral Res; 2011 Apr; 90(1):1-8. PubMed ID: 21310183
    [TBL] [Abstract][Full Text] [Related]  

  • 76. An Overview of Monoclonal Antibodies.
    Bayer V
    Semin Oncol Nurs; 2019 Oct; 35(5):150927. PubMed ID: 31488319
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Preparation of single chain variable fragment of MG(7) mAb by phage display technology.
    Yu ZC; Ding J; Nie YZ; Fan DM; Zhang XY
    World J Gastroenterol; 2001 Aug; 7(4):510-4. PubMed ID: 11819819
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Recombinant antibodies and in vitro selection technologies.
    Geyer CR; McCafferty J; Dübel S; Bradbury AR; Sidhu SS
    Methods Mol Biol; 2012; 901():11-32. PubMed ID: 22723092
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Hybridoma-free generation of monoclonal antibodies.
    Pasqualini R; Arap W
    Proc Natl Acad Sci U S A; 2004 Jan; 101(1):257-9. PubMed ID: 14688405
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Monoclonal antibodies for cancer immunotherapy.
    Weiner LM; Dhodapkar MV; Ferrone S
    Lancet; 2009 Mar; 373(9668):1033-40. PubMed ID: 19304016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.